RPR Submits Applications in 16
Selected Abstract
RPR Submits Applications in 16 European Countries For Drug to Treat Unstable Angina
COLLEGEVILLE, Pa. and ANTONY, France, June 17 /PRNewswire/ -- Rhone-Poulenc Rorer Inc. (NYSE: RPR) announced today that it has submitted applications for marketing clearance in 16 European countries (Belgium, Denmark, Finland, France, Germany, Greece, the Netherlands, Italy, Luxembourg, Norway, ... June 17, 1997; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
RPR Submits Applications in 16 European Countries For Drug to Treat Unstable Angina
|
